Board of Directors

The 13-member CADTH Board of Directors is composed of an independent chair; a regional distribution of jurisdictional federal, provincial, and territorial representatives; and a number of non-jurisdictional representatives from health systems, academia, and the general public. Directors are elected by the Members of the Corporation, who are the Deputy Ministers of Health for participating federal, provincial, and territorial governments.

The Board has overall responsibility for administering the affairs of the Corporation and providing the strategic direction to guide CADTH's success as the Canadian "go-to" provider of evidence and advice on the use of drugs and other health technologies.

Chair of the Board

David AgnewDavid Agnew


EricEric Bélair
Associate Assistant Deputy Minister, Strategic Policy Branch Health Canada


Western Provinces

Mark WyattMark Wyatt
Assistant Deputy Minister, Saskatchewan Ministry of Health

Chad MitchellChad Mitchell
ADM, Pharmaceutical and Supplementary Benefits Division Alberta Health


To be appointed


Patrick DicerniMr. Patrick Dicerni
Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs 

Atlantic Provinces

Jeannine LagasséJeannine Lagassé
Deputy Minister of Health and Wellness, Province of Nova Scotia.

                        Heidi Liston

Health Systems

Hamida BhimaniHamida Bhimani
Healthcare Executive, Leadership and Diversity Consultant

Dr. Charmaine RoyeDr. Charmaine Roye
Physician, Ottawa


Cathy McIntyreCathy McIntyre
Principal of Strategic Initiatives

Ellen PekilisEllen Pekilis
Legal, Risk and Governance Advisor


Dr. Avram DenburgDr. Avram Denburg
Oncologist and Clinician-Scientist
Hematology/Oncology Division
Hospital for Sick Children

Observer (Quebec)

                              Dr. Michele de Guise
                              President and CEO of INESSS